Assessing evidence with the minimum of observer bias is central to scientific enquiry and hypothesis testing-so central it seems quite unnecessary to remind ourselves of this. Yet many doctors are principally scientists of the "classification" school, perhaps partly as a consequence of the extent of medical knowledge, the length of medical training, and the amount of information to be learnt by rote; and many researching scientists operate more as "technicians", perhaps partly as a consequence of academic competition, pressure to
publish, and pressure to maintain grant income. With an ever increasing medical and scientific literature and an ever increasing complexity of medical research, it is important that both medical research scientists and leading clinicians are able to assess the evidence and appraise the literature critically and to minimise personal bias while doing so.
Medical schools are becoming increasingly conscious of this need and courses for undergraduate medical students and short courses for registrars, seeking guidance in research training, are designed specifically to address the issue of "critical appraisal ofpublished medical/scientific evidence". 14 These developments and courses are generally based in epidemiology (or social medicine, community medicine, or public health) departments. Techniques of"critical appraisal" are useful in their own right but what is possibly being missed in these developments is discussion of the fundamental principles underlying the need for these techniques; that is, to minimise as far as possible personal biases of the hypothesis generators and testers, observers, experimenters, and readers.
Historians and philosophers of science have taught how scientific knowledge advances often not as a smooth logical progression but in quantum leaps from one established paradigm to another and furthermore that it often takes many attempts to leave the security of one consensus theory, truth, or fact before it is suddenly appreciated that the new theory is truer and fits the observations better than the old."7 With the wisdom of hindsight many outspoken advocates of the "flat earth society" became equally vociferous supporters of the planetary theory of the solar system. The challenge for the practising scientist is to identify the elements of data that do not fit the flat earth theory, when that is the predominant and socially accepted reigning theory, and to proffer alternative explanations, hypotheses, or theories.
With this background it is salutary to consider a recent "case study", which is in itself an important case since it relates to control ofone ofthe primary risk factors ofthe leading cause of death in the western world, and correct interpretation of the literature is important for public health as presently practised. The association between serum cholesterol and mortality from heart disease observed in cross sectional, case-control, and cohort studies led to major population wide experimental evaluation of cholesterol lowering regimens. A number (more than 20) of important primary prevention trials have been undertaken, utilising diet modification or cholesterol lowering medication. The accumulating evidence has been and no doubt will continue to be reviewed. 8'0 Reviewing used to be (mostly) an "art", practised by elder statesmen of the subject, drawing on their accumulated experience and wisdom, sometimes possibly with statistical and other specialist advice in the background. In recent years this "art" had been given a more scientific basis by the introduction of the statistical overview or meta-analysis." 12 For those unfamiliar with the statistical overview, the technique may be described simply as selecting from published reports trials testing a common hypothesis and satisfying certain criteria of patient selection (or exclusion), intervention (drug or operation), completeness of recording and follow up, and measurement of outcome, and then calculating the average effect of the selected trials.
A recent review of cholesterol lowering and mortality was such a statistical overview (or meta-analysis) of six selected primary trials. It appeared under the familiar format of a scientific paper, with introduction, methods, results, and discussion.13 This in itself could be misleading for cursory or skimming readers, unfamiliar with the recent developments in statistical overviews, since the article, despite its title, could be mistaken for a new and very large primary trial. The average finding of the trials included in that statistical overview was that there was no benefit of lowering cholesterol with respect to total mortality, although there may have been a transfer of cause of death from heart disease to other causes: the review highlighted suicide and violence. The review led, not perhaps surprisingly, to a somewhat excited correspondence (BMJ 15 September and 6 October, 1990 ). The range of reactions was wide, as the authors observed in their response: "We are said to have both understated and overstated the adverse effects".
While discussion is essential for the advancement of science and good debate is an important part of that essential discussion, some ofthe arguments used in this correspondence are disquieting for medical science and perhaps particularly so for epidemiology as a discipline, if epidemiologists wish to be the "guardians of rational appraisal of medical/scientific evidence"." It is not the intention here to cap the extensive reviewing of the cholesterol story, but to draw attention to some illogicalities and irrationalities in arguments presented and the powerful influence of the reigning consensus expert view. It was after all a "case history" and not in any way unique, since debate or argument surrounds many reports and publications. We are concerned here about general issues of the rationality of scientific debate, the assessment of scientific evidence, and the development of scientific knowledge.
Medical scientists and epidemiologists in particular teach the next generation of medical scientists and doctors that the randomised controlled trial sits at the head of a "hierarchy of evidence"3 and is the best demonstration of cause and effect, that bigger trials have more power than smaller trials, and that many trials are more representative than single trials. Yet as this "case study" shows, medical scientists, including epidemiologists, when faced by the pooled results of many large randomised trials that appear to contradict their "prior beliefmodel" or the "consensus view" may abandon their own teaching and recommend instead the weaker evidence of observational studies and even weaker and more subjective observations of clinical experience. Such is the power of "scientific consensus", conformity within the scientific community, or "personal prejudice". There are acknowledged problems with the statistical overview, which have been discussed more fully elsewhere.'4 15 The principal problem arises through the selection of evidence post hoc, which clearly contradicts a fundamental scientific principle of postulating hypotheses and then designing experiments to test the hypotheses. It is also true that this particular statistical overview of cholesterol lowering trials was highly selective (six of more than 20 trials). Nevertheless it is apparent that emotion contributed to the correspondence that emanated from this case.
Research scientists and epidemiologists working in the abstract and with the population approach, are very familiar with the concept of bias and the possible effects of bias on scientific observation. We may not, however, fully appreciate the "inevitability of prejudice"'6 and that we may be as humanly subject to prejudice as the non-scientifically trained. Scientists should be sufficiently self critical to be aware that they may enter a debate with an established prior belief, bias, or prejudice, cling to those beliefs for the security and respectability which accompany conformity, and seek to maintain established medical or scientific paradigms by selecting evidence that supports those beliefs or paradigms. It is widely recognised that it takes a lot to dislodge established consensus views or explanatory models and to replace the old with new explanatory models5'6 although scientific philosophers have suggested that correction is as important as accumulation for the advancement of scientific knowledge.7 17 The history of science is replete with examples.
To return briefly to the cholesterol story before citing other epidemiological examples, it is perhaps time for revision of the current consensus paradigm (paraphrased very simply as) "cholesterol causes heart disease and heart disease leads to death, therefore cholesterol leads to death and consequently lowering cholesterol averts death", in the light of the pooled evidence of large ramdomised controlled trials. Another example in cardiovascular epidemiology is the debate surrounding exercise based rehabilitation following myocardial infarction. Briefly, the WXHO European rehabilitation trials group reported no net life saving benefit (one centre better, one worse, others non-significant).18 However, those trials were evaluating multifactorial programmes and more recently statistical overviews of selected trials (from the WHO group and from elsewhere) in which exercise was believed (by the post hoc overviewers) to be the active ingredient have suggested a 20% net reduction in mortality. ' 
